BeiGene
BGNE
#911
Rank
ยฃ17.40 B
Marketcap
ยฃ154.55
Share price
0.15%
Change (1 day)
4.84%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company